FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1293-1304 March 31, 2005 Number 13 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Levin, R. I. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Randomized trials have shown that low-dose aspirin decreases the risk of a first myocardial infarction in men, with little effect on the risk of ischemic stroke. There are few similar data in women.

Methods We randomly assigned 39,876 initially healthy women 45 years of age or older to receive 100 mg of aspirin on alternate days or placebo and then monitored them for 10 years for a first major cardiovascular event (i.e., nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes).

Results During follow-up, 477 major cardiovascular events were confirmed in the aspirin group, as compared with 522 in the placebo group, for a nonsignificant reduction in risk with aspirin of 9 percent (relative risk, 0.91; 95 percent confidence interval, 0.80 to 1.03; P=0.13). With regard to individual end points, there was a 17 percent reduction in the risk of stroke in the aspirin group, as compared with the placebo group (relative risk, 0.83; 95 percent confidence interval, 0.69 to 0.99; P=0.04), owing to a 24 percent reduction in the risk of ischemic stroke (relative risk, 0.76; 95 percent confidence interval, 0.63 to 0.93; P=0.009) and a nonsignificant increase in the risk of hemorrhagic stroke (relative risk, 1.24; 95 percent confidence interval, 0.82 to 1.87; P=0.31). As compared with placebo, aspirin had no significant effect on the risk of fatal or nonfatal myocardial infarction (relative risk, 1.02; 95 percent confidence interval, 0.84 to 1.25; P=0.83) or death from cardiovascular causes (relative risk, 0.95; 95 percent confidence interval, 0.74 to 1.22; P=0.68). Gastrointestinal bleeding requiring transfusion was more frequent in the aspirin group than in the placebo group (relative risk, 1.40; 95 percent confidence interval, 1.07 to 1.83; P=0.02). Subgroup analyses showed that aspirin significantly reduced the risk of major cardiovascular events, ischemic stroke, and myocardial infarction among women 65 years of age or older.

Conclusions In this large, primary-prevention trial among women, aspirin lowered the risk of stroke without affecting the risk of myocardial infarction or death from cardiovascular causes, leading to a nonsignificant finding with respect to the primary end point.

Source Information

From the Divisions of Preventive Medicine (P.MR., N.R.C., I-M.L., D.G., J.M.G., J.E.M., J.E.B.), Cardiovascular Medicine (P.MR., J.M.G.), and Aging (J.M.G., J.E.B.), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; the Department of Epidemiology, Harvard School of Public Health (P.MR., N.R.C., I-M.L., J.E.M., J.E.B.); Veterans Affairs Boston Healthcare System (J.M.G.); and the Department of Ambulatory Care and Prevention, Harvard Medical School (J.E.B.) — all in Boston; and the Departments of Medicine and Epidemiology and Public Health, University of Miami School of Medicine, and the Department of Biomedical Science, Center of Excellence, Florida Atlantic University, Miami (C.H.H.).

This article was published at www.nejm.org on March 7, 2005.

Address reprint requests to Dr. Buring at the Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Ave. East, Boston, MA 02215, or at jburing{at}rics.bwh.harvard.edu.

Full Text of this Article

Related Letters:

Aspirin in the Prevention of Cardiovascular Disease in Women
Schwartz D. J., Dalen J. E., Ridker P. M., Buring J. E.
Extract | Full Text | PDF  
N Engl J Med 2005; 352:2751-2752, Jun 30, 2005. Correspondence

This article has been cited by other articles:

• Ishitani, K., Lin, J., Manson, J. E., Buring, J. E., Zhang, S. M. (2008). A Prospective Study of Multivitamin Supplement Use and Risk of Breast Cancer. Am J Epidemiol 167: 1197-1206 [Abstract] [Full Text]  
• Gasparyan, A. Y., Watson, T., Lip, G. Y.H. (2008). The Role of Aspirin in Cardiovascular Prevention: Implications of Aspirin Resistance. J Am Coll Cardiol 51: 1829-1843 [Abstract] [Full Text]  
• Malarstig, A., Eriksson, P., Rose, L., Diehl, K. A., Hamsten, A., Ridker, P. M, Zee, R. Y.L. (2008). Genetic Variants of Tumor Necrosis Factor Superfamily, Member 4 (TNFSF4), and Risk of Incident Atherothrombosis and Venous Thromboembolism. Clin. Chem. 54: 833-840 [Abstract] [Full Text]  
• Rexrode, K. M., Ridker, P. M., Hegener, H. H., Buring, J. E., Manson, J. E., Zee, R. Y.L. (2008). Genetic Variation of the Androgen Receptor and Risk of Myocardial Infarction and Ischemic Stroke in Women. Stroke 39: 1590-1592 [Abstract] [Full Text]  
• Weinstein, A. R., Sesso, H. D., Lee, I-M., Rexrode, K. M., Cook, N. R., Manson, J. E., Buring, J. E., Gaziano, J. M. (2008). The Joint Effects of Physical Activity and Body Mass Index on Coronary Heart Disease Risk in Women. Arch Intern Med 168: 884-890 [Abstract] [Full Text]  
• LaCroix, A. Z., Gray, S. L., Aragaki, A., Cochrane, B. B., Newman, A. B., Kooperberg, C. L., Black, H., Curb, J. D., Greenland, P., Woods, N. F. (2008). Statin Use and Incident Frailty in Women Aged 65 Years or Older: Prospective Findings From the Women's Health Initiative Observational Study. J. Gerontol. A Biol. Sci. Med. Sci. 63: 369-375 [Abstract] [Full Text]  
• Lin, J., Lee, I-M., Cook, N. R, Selhub, J., Manson, J. E, Buring, J. E, Zhang, S. M (2008). Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am. J. Clin. Nutr. 87: 734-743 [Abstract] [Full Text]  
• Jackson, G. (2008). Gender differences in cardiovascular disease prevention. Menopause Int 14: 13-17 [Abstract] [Full Text]  
• Rees, M., Stevenson, J., on behalf of the British Menopause Society Council, (2008). Primary prevention of coronary heart disease in women. Menopause Int 14: 40-45 [Abstract] [Full Text]  
• Patrono, C., Rocca, B. (2008). Aspirin: Promise and Resistance in the New Millennium. Arterioscler. Thromb. Vasc. Bio. 28: s25-s32 [Abstract] [Full Text]  
• Pradhan, A. D., Shrivastava, S., Cook, N. R., Rifai, N., Creager, M. A., Ridker, P. M (2008). Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk. Circulation 117: 823-831 [Abstract] [Full Text]  
• Ridker, P. M, Chasman, D. I., Zee, R. Y.L., Parker, A., Rose, L., Cook, N. R., Buring, J. E, for the Women's Genome Health Study Working Group, (2008). Rationale, Design, and Methodology of the Women's Genome Health Study: A Genome-Wide Association Study of More Than 25 000 Initially Healthy American Women. Clin. Chem. 54: 249-255 [Abstract] [Full Text]  
• Wienbergen, H., Senges, J., Gitt, A. K. (2008). Should We Prescribe Statin and Aspirin for Every Diabetic Patient?: Is it time for a polypill?. Diabetes Care 31: S222-S225 [Full Text]  
• Shiffman, D., Chasman, D. I., Zee, R. Y.L., Iakoubova, O. A., Louie, J. Z., Devlin, J. J., Ridker, P. M. (2008). A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study.. J Am Coll Cardiol 51: 444-448 [Abstract] [Full Text]  
• Mizuno, K., Nakaya, N., Ohashi, Y., Tajima, N., Kushiro, T., Teramoto, T., Uchiyama, S., Nakamura, H., for the MEGA Study Group, (2008). Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women: Analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA Study). Circulation 117: 494-502 [Abstract] [Full Text]  
• Dhruva, S. S., Redberg, R. F. (2008). Variations Between Clinical Trial Participants and Medicare Beneficiaries in Evidence Used for Medicare National Coverage Decisions. Arch Intern Med 168: 136-140 [Abstract] [Full Text]  
• Tworoger, S. S., Lee, I-M., Buring, J. E., Hankinson, S. E. (2008). Plasma Androgen Concentrations and Risk of Incident Ovarian Cancer. Am J Epidemiol 167: 211-218 [Abstract] [Full Text]  
• Christen, W. G., Liu, S., Glynn, R. J., Gaziano, J. M., Buring, J. E. (2008). Dietary Carotenoids, Vitamins C and E, and Risk of Cataract in Women: A Prospective Study. Arch Ophthalmol 126: 102-109 [Abstract] [Full Text]  
• Kardys, I., Rifai, N., Meilhac, O., Michel, J.-B., Martin-Ventura, J. L., Buring, J. E., Libby, P., Ridker, P. M (2008). Plasma Concentration of Heat Shock Protein 27 and Risk of Cardiovascular Disease: A Prospective, Nested Case-Control Study. Clin. Chem. 54: 139-146 [Abstract] [Full Text]  
• Conen, D., Ridker, P. M., Mora, S., Buring, J. E., Glynn, R. J. (2007). Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study. Eur Heart J 28: 2937-2943 [Abstract] [Full Text]  
• Zee, R. Y.L., Cheng, S., Erlich, H. A., Lindpaintner, K., Rifai, N., Buring, J. E., Ridker, P. M (2007). Intercellular Adhesion Molecule 1 (ICAM1) Lys56Met and Gly241Arg Gene Variants, Plasma-Soluble ICAM1 Concentrations, and Risk of Incident Cardiovascular Events in 23 014 Initially Healthy White Women. Stroke 38: 3152-3157 [Abstract] [Full Text]  
• Conen, D., Glynn, R. J., Buring, J. E., Ridker, P. M, Zee, R. Y.L. (2007). Natriuretic Peptide Precursor A Gene Polymorphisms and Risk of Blood Pressure Progression and Incident Hypertension. Hypertension 50: 1114-1119 [Abstract] [Full Text]  
• Bowman, T. S., Gaziano, J. M., Buring, J. E., Sesso, H. D. (2007). A Prospective Study of Cigarette Smoking and Risk of Incident Hypertension in Women. J Am Coll Cardiol 50: 2085-2092 [Abstract] [Full Text]  
• Bhatt, D. L. (2007). Intensifying Platelet Inhibition -- Navigating between Scylla and Charybdis. NEJM 357: 2078-2081 [Full Text]  
• Barrett, K. M., Worrall, B. B. (2007). Sex and stroke: Are they really different in midlife?. Neurology 69: 1894-1895 [Full Text]  
• Towfighi, A., Saver, J. L., Engelhardt, R., Ovbiagele, B. (2007). A midlife stroke surge among women in the United States. Neurology 69: 1898-1904 [Abstract] [Full Text]  
• Mora, S., Cook, N., Buring, J. E., Ridker, P. M, Lee, I-M. (2007). Physical Activity and Reduced Risk of Cardiovascular Events: Potential Mediating Mechanisms. Circulation 116: 2110-2118 [Abstract] [Full Text]  
• Sander, K., Schulze Horn, C., Briesenick, C., Sander, D. (2007). High-Sensitivity C-Reactive Protein Is Independently Associated With Early Carotid Artery Progression in Women But Not in Men: The INVADE Study. Stroke 38: 2881-2886 [Abstract] [Full Text]  
• Glynn, R. J., Ridker, P. M, Goldhaber, S. Z., Buring, J. E. (2007). Effect of Low-Dose Aspirin on the Occurrence of Venous Thromboembolism: A Randomized Trial. ANN INTERN MED 147: 525-533 [Abstract] [Full Text]  
• Jull, A. (2007). How to write a commentary an editor's perspective. Evid. Based Nurs. 10: 100-103 [Full Text]  
• Authors/Task Force Members, , Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., Gjelsvik, B., Herrmann-Lingen, C., Hoes, A., Humphries, S., Knapton, M., Perk, J., Priori, S. G., Pyorala, K., Reiner, Z., Ruilope, L., Sans-Menendez, S., Scholte op Reimer, W., Weissberg, P., Wood, D., Yarnell, J., Zamorano, J. L., Other experts who contributed to parts of the guid, , Walma, E., Fitzgerald, T., Cooney, M. T., Dudina, A., European Society of Cardiology (ESC) Committee for, , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Funck-Brentano, C., Filippatos, G., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document reviewers:, , Hellemans, I., Altiner, A., Bonora, E., Durrington, P. N., Fagard, R., Giampaoli, S., Hemingway, H., Hakansson, J., Kjeldsen, S. E., Larsen, M. L., Mancia, G., Manolis, A. J., Orth-Gomer, K., Pedersen, T., Rayner, M., Ryden, L., Sammut, M., Schneiderman, N., Stalenhoef, A. F., Tokgozoglu, L., Wiklund, O., Zampelas, A. (2007). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 28: 2375-2414 [Full Text]  
• Rexrode, K. M., Ridker, P. M., Hegener, H. H., Buring, J. E., Manson, J. E., Zee, R. Y.L. (2007). Polymorphisms and Haplotypes of the Estrogen Receptor-{beta} Gene (ESR2) and Cardiovascular Disease in Men and Women. Clin. Chem. 53: 1749-1756 [Abstract] [Full Text]  
• Glynn, R. J., Ridker, P. M, Goldhaber, S. Z., Zee, R. Y.L., Buring, J. E. (2007). Effects of Random Allocation to Vitamin E Supplementation on the Occurrence of Venous Thromboembolism: Report From the Women's Health Study. Circulation 116: 1497-1503 [Abstract] [Full Text]  
• Wang, T. H., Bhatt, D. L., Fox, K. A.A., Steinhubl, S. R., Brennan, D. M., Hacke, W., Mak, K.-H., Pearson, T. A., Boden, W. E., Steg, P. G., Flather, M. D., Montalescot, G., Topol, E. J., on behalf of the CHARISMA Investigators, (2007). An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. Eur Heart J 28: 2200-2207 [Abstract] [Full Text]  
• Conen, D., Ridker, P. M, Buring, J. E, Glynn, R. J (2007). Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ 335: 432-432 [Abstract] [Full Text]  
• Nicolucci, A., De Berardis, G., Sacco, M., Tognoni, G. (2007). AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions. Eur Heart J 28: 1925-1927 [Abstract] [Full Text]  
• Tworoger, S. S., Lee, I-M., Buring, J. E., Pollak, M. N., Hankinson, S. E. (2007). Insulin-like Growth Factors and Ovarian Cancer Risk: A Nested Case-Control Study in Three Cohorts. Cancer Epidemiol. Biomarkers Prev. 16: 1691-1695 [Abstract] [Full Text]  
• Sesso, H. D., Gaziano, J. M., Jenkins, D. J.A., Buring, J. E. (2007). Strawberry Intake, Lipids, C-Reactive Protein, and the Risk of Cardiovascular Disease in Women. J. Am. Coll. Nutr. 26: 303-310 [Abstract] [Full Text]  
• Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., Ridker, P. M (2007). Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women. JAMA 298: 309-316 [Abstract] [Full Text]  
• Authors/Task Force Members:, , Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker Boudier, H. A.J., Zanchetti, A., ESC Committee for Practice Guidelines (CPG):, , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., ESH Scientific Council:, , Kjeldsen, S. E., Erdine, S., Narkiewicz, K., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Cifkova, R., Dominiczak, A., Fagard, R., Heagerty, A. M., Laurent, S., Lindholm, L. H., Mancia, G., Manolis, A., Nilsson, P. M., Redon, J., Schmieder, R. E., Struijker-Boudier, H. A.J., Viigimaa, M., Document Reviewers:, , Filippatos, G., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., Clement, D., Erdine, S., Farsang, C., Gaita, D., Kiowski, W., Lip, G., Mallion, J.-M., Manolis, A. J., Nilsson, P. M., O'Brien, E., Ponikowski, P., Redon, J., Ruschitzka, F., Tamargo, J., van Zwieten, P., Viigimaa, M., Waeber, B., Williams, B., Zamorano, J. L. (2007). 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 0: ehm236v1-75 [Full Text]  
• Bardia, A., Ebbert, J. O., Vierkant, R. A., Limburg, P. J., Anderson, K., Wang, A. H., Olson, J. E., Vachon, C. M., Cerhan, J. R. (2007). Association of Aspirin and Nonaspirin Nonsteroidal Anti-inflammatory Drugs With Cancer Incidence and Mortality. JNCI J Natl Cancer Inst 99: 881-889 [Abstract] [Full Text]  
• Zhang, S. M., Lin, J., Cook, N. R., Lee, I-M., Manson, J. E., Buring, J. E., Ridker, P. M. (2007). C-Reactive Protein and Risk of Breast Cancer. JNCI J Natl Cancer Inst 99: 890-894 [Abstract] [Full Text]  
• Beckley, E. T. (2007). Women Need Tailored CHD Prevention. DOC News 4: 5-5 [Full Text]  
• Nicolucci, A., De Berardis, G., Sacco, M., Tognoni, G. (2007). Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association: Response to Buse et al.. Diabetes Care 30: e57-e57 [Full Text]  
• Lin, J., Manson, J. E., Lee, I-M., Cook, N. R., Buring, J. E., Zhang, S. M. (2007). Intakes of Calcium and Vitamin D and Breast Cancer Risk in Women. Arch Intern Med 167: 1050-1059 [Abstract] [Full Text]  
• Freedman, J. E. (2007). Heritability, Platelet Function, and Aspirin: A Link Established but Cause Unknown. Circulation 115: 2468-2470 [Full Text]  
• Faraday, N., Yanek, L. R., Mathias, R., Herrera-Galeano, J. E., Vaidya, D., Moy, T. F., Fallin, M. D., Wilson, A. F., Bray, P. F., Becker, L. C., Becker, D. M. (2007). Heritability of Platelet Responsiveness to Aspirin in Activation Pathways Directly and Indirectly Related to Cyclooxygenase-1. Circulation 115: 2490-2496 [Abstract] [Full Text]  
• Ding, E. L., Powe, N. R., Manson, J. E., Sherber, N. S., Braunstein, J. B. (2007). Sex Differences in Perceived Risks, Distrust, and Willingness to Participate in Clinical Trials: A Randomized Study of Cardiovascular Prevention Trials. Arch Intern Med 167: 905-912 [Abstract] [Full Text]  
• Kang, J. H., Cook, N., Manson, J., Buring, J. E, Grodstein, F. (2007). Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ 334: 987-987 [Abstract] [Full Text]  
• Meadows, T. A., Bhatt, D. L. (2007). Clinical Aspects of Platelet Inhibitors and Thrombus Formation. Circ. Res. 100: 1261-1275 [Abstract] [Full Text]  
• Campbell, C. L., Smyth, S., Montalescot, G., Steinhubl, S. R. (2007). Aspirin Dose for the Prevention of Cardiovascular Disease: A Systematic Review. JAMA 297: 2018-2024 [Abstract] [Full Text]  
• Zee, R. Y.L., Mora, S., Cheng, S., Erlich, H. A., Lindpaintner, K., Rifai, N., Buring, J. E., Ridker, P. M (2007). Homocysteine, 5,10-Methylenetetrahydrofolate Reductase 677C>T Polymorphism, Nutrient Intake, and Incident Cardiovascular Disease in 24 968 Initially Healthy Women. Clin. Chem. 53: 845-851 [Abstract] [Full Text]  
• Dorsch, M. P, Lee, J. S., Lynch, D. R, Dunn, S. P, Rodgers, J. E, Schwartz, T., Colby, E., Montague, D., Smyth, S. S (2007). Aspirin Resistance in Patients with Stable Coronary Artery Disease with and without a History of Myocardial Infarction. The Annals of Pharmacotherapy 41: 737-741 [Abstract] [Full Text]  
• Maree, A. O., Fitzgerald, D. J. (2007). Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease. Circulation 115: 2196-2207 [Full Text]  
• Tworoger, S. S., Lee, I-M., Buring, J. E., Rosner, B., Hollis, B. W., Hankinson, S. E. (2007). Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Incident Ovarian Cancer. Cancer Epidemiol. Biomarkers Prev. 16: 783-788 [Abstract] [Full Text]  
• Lin, J., Zhang, S. M., Cook, N. R., Manson, J. E., Buring, J. E., Lee, I-M. (2007). Oral Contraceptives, Reproductive Factors, and Risk of Colorectal Cancer among Women in a Prospective Cohort Study. Am J Epidemiol 165: 794-801 [Abstract] [Full Text]  
• Ivandic, B. T., Giannitsis, E., Schlick, P., Staritz, P., Katus, H. A., Hohlfeld, T. (2007). Determination of Aspirin Responsiveness by Use of Whole Blood Platelet Aggregometry. Clin. Chem. 53: 614-619 [Abstract] [Full Text]  
• Baron, J. A. (2007). Can Aspirin Keep Mortality at Bay?. Arch Intern Med 167: 535-536 [Full Text]  
• Chan, A. T., Manson, J. E., Feskanich, D., Stampfer, M. J., Colditz, G. A., Fuchs, C. S. (2007). Long-term Aspirin Use and Mortality in Women. Arch Intern Med 167: 562-572 [Abstract] [Full Text]  
• Zhang, S. M., Lee, I-M., Manson, J. E., Cook, N. R., Willett, W. C., Buring, J. E. (2007). Alcohol Consumption and Breast Cancer Risk in the Women's Health Study. Am J Epidemiol 165: 667-676 [Abstract] [Full Text]  
• Pilote, L., Dasgupta, K., Guru, V., Humphries, K. H., McGrath, J., Norris, C., Rabi, D., Tremblay, J., Alamian, A., Barnett, T., Cox, J., Ghali, W. A., Grace, S., Hamet, P., Ho, T., Kirkland, S., Lambert, M., Libersan, D., O'Loughlin, J., Paradis, G., Petrovich, M., Tagalakis, V. (2007). A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 176: S1-S44 [Abstract] [Full Text]  
• Barrett-Connor, E. (2007). Women and cardiovascular disease. CMAJ 176: 791-793 [Full Text]  
• Schaumberg, D. A., Christen, W. G., Buring, J. E., Glynn, R. J., Rifai, N., Ridker, P. M. (2007). High-Sensitivity C-Reactive Protein, Other Markers of Inflammation, and the Incidence of Macular Degeneration in Women. Arch Ophthalmol 125: 300-305 [Abstract] [Full Text]  
• Zhang, S. M., Manson, J. E., Rexrode, K. M., Cook, N. R., Buring, J. E., Lee, I-M. (2007). Use of Oral Conjugated Estrogen Alone and Risk of Breast Cancer. Am J Epidemiol 165: 524-529 [Abstract] [Full Text]  
• Kurth, T., Everett, B. M., Buring, J. E., Kase, C. S., Ridker, P. M., Gaziano, J. M. (2007). Lipid levels and the risk of ischemic stroke in women. Neurology 68: 556-562 [Abstract] [Full Text]  
• Cook, N. R. (2007). Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction. Circulation 115: 928-935 [Abstract] [Full Text]  
• Ridker, P. M, Buring, J. E., Rifai, N., Cook, N. R. (2007). Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score. JAMA 297: 611-619 [Abstract] [Full Text]  
• Bates, E. R., Babb, C. J. D., Casey, D. E., Cates, C. U., Duckwiler, G. R., Feldman, T. E., Gray, W. A., Ouriel, K., Peterson, E. D., Rosenfield, K., Rundback, J. H., Safian, R. D., Sloan, M. A., White, C. J. (2007). ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). Vasc Med 12: 35-83  
• Samuels, M. A. (2007). Update in Neurology. ANN INTERN MED 146: 128-132 [Full Text]  
• American Society of Interventional & Therapeutic N, , Society for Cardiovascular Angiography and Interve, , Society for Vascular Medicine and Biology, , Society of Interventional Radiology, , Bates, E. R., Babb, J. D., Casey, D. E. Jr, Cates, C. U., Duckwiler, G. R., Feldman, T. E., Gray, W. A., Ouriel, K., Peterson, E. D., Rosenfield, K., Rundback, J. H., Safian, R. D., Sloan, M. A., White, C. J., Harrington, R. A., Abrams, J., Anderson, J. L., Bates, E. R., Eisenberg, M. J., Grines, C. L., Hlatky, M. A., Lichtenberg, R. C., Lindner, J. R., Pohost, G. M., Schofield, R. S., Shubrooks, S. J. JR, Stein, J. H., Tracy, C. M., Vogel, R. A., Wesley, D. J. (2007). ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). J Am Coll Cardiol 49: 126-170 [Full Text]  
• Bibbins-Domingo, K., Fernandez, A. (2007). BiDil for Heart Failure in Black Patients: Implications of the U.S. Food and Drug Administration Approval. ANN INTERN MED 146: 52-56 [Abstract] [Full Text]  
• Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., Pignone, M. P., Plutzky, J., Porte, D., Redberg, R., Stitzel, K. F., Stone, N. J. (2007). Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation 115: 114-126 [Abstract] [Full Text]  
• (2007). Analyzing the Risks and Benefits of Aspirin. DOC News 4: 4-4 [Full Text]  
• Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., Pignone, M. P., Plutzky, J., Porte, D., Redberg, R., Stitzel, K. F., Stone, N. J. (2007). Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 30: 162-172 [Abstract] [Full Text]  
• Carandang, R., Seshadri, S., Beiser, A., Kelly-Hayes, M., Kase, C. S., Kannel, W. B., Wolf, P. A. (2006). Trends in Incidence, Lifetime Risk, Severity, and 30-Day Mortality of Stroke Over the Past 50 Years. JAMA 296: 2939-2946 [Abstract] [Full Text]  
• Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation 114: 2871-2891 [Full Text]  
• Albert, M. A., Glynn, R. J., Buring, J., Ridker, P. M (2006). Impact of Traditional and Novel Risk Factors on the Relationship Between Socioeconomic Status and Incident Cardiovascular Events. Circulation 114: 2619-2626 [Abstract] [Full Text]  
• Kang, J. H., Cook, N., Manson, J., Buring, J. E., Grodstein, F. (2006). A Randomized Trial of Vitamin E Supplementation and Cognitive Function in Women. Arch Intern Med 166: 2462-2468 [Abstract] [Full Text]  
• Shadick, N. A., Cook, N. R., Karlson, E. W., Ridker, P. M, Maher, N. E., Manson, J. E., Buring, J. E., Lee, I.-M. (2006). C-Reactive Protein in the Prediction of Rheumatoid Arthritis in Women. Arch Intern Med 166: 2490-2494 [Abstract] [Full Text]  
• Everett, B. M., Kurth, T., Buring, J. E., Ridker, P. M. (2006). The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women. J Am Coll Cardiol 48: 2235-2242 [Abstract] [Full Text]  
• Napoli, C., Lerman, L. O., de Nigris, F., Gossl, M., Balestrieri, M. L., Lerman, A. (2006). Rethinking Primary Prevention of Atherosclerosis-Related Diseases. Circulation 114: 2517-2527 [Full Text]  
• Biondi-Zoccai, G. G.L., Lotrionte, M., Agostoni, P., Abbate, A., Fusaro, M., Burzotta, F., Testa, L., Sheiban, I., Sangiorgi, G. (2006). A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 27: 2667-2674 [Abstract] [Full Text]  
• Rosenfeld, A. G. (2006). State of the Heart: Building Science to Improve Women's Cardiovascular Health. Am J Crit Care 15: 556-566 [Abstract] [Full Text]  
• Lin, J., Cook, N. R., Lee, I-M., Manson, J. E., Buring, J. E., Zhang, S. M. (2006). Total magnesium intake and colorectal cancer incidence in women.. Cancer Epidemiol. Biomarkers Prev. 15: 2006-2009 [Full Text]  
• (2006). Aspirin for Primary Prevention of Cardiovascular Disease (Revisited). Obstet Gynecol 108: 1023-1023 [Full Text]